Stocks Regain Analysts Interests: Occidental Petroleum (NYSE:OXY), Sibanye Gold (NYSE:SBGL)

Occidental Petroleum Corporation (NYSE:OXY) [Trend Analysis] retains strong position in active trade, as shares scoring -0.20% to $64.73 in active trade session, while looking at the shares volume, around 5.08 Million shares have changed hands in this session. Finally, analysts shed their light over the OXY price targets; maintaining price high target of 91.00 while at average the price target was 74.21 in contrast with the current price of 64.73. The price targets are usually acts as the boosters or blasters in the performance of stock. A higher price target would definitely provide confidence to investors during the trading action, consideration given by Wall Street Journal.

So does the rankings given by analysts; let us highlight rankings table and we had 4 analysts recommending BUY ratings for current month and for previous month 7 stands on similar situation; while 19 for the current month as compared to 17 analysts recommending for HOLD from the pool for previous month. While 2 stands at overweight and 2 out of pool consider it as sell for current month. For the overall, consensus ratings were for Hold.

The firm has institutional ownership of 84.20%, while insider ownership included 0.20%. OXY attains analyst recommendation of 2.80 with week’s performance of -1.13%. Investors looking further ahead will note that the Price to next year’s EPS is 77.11%.

Sibanye Gold Limited (NYSE:SBGL) [Trend Analysis] knocking active thrust in leading trading session, shares a loss of -2.66% to 7.69 with around 1.93 Million shares have changed hands in this session. Fundamentalist can give brighter side of a picture but an analyst can glow the darker parts stored in any investment. Let us view how analysts have ranked SBGL in recent few months. In ratings table the SBGL given BUY ratings by 3 analysts in current phase. The 2 number of analyst/s have SELL recommendation for current month on SBGL. While 6 number of analysts gave ratings for HOLD in current as compared to 1 analyst giving UNDERWEIGHT. As per remarks given by WSJ, overall consensus pool recommends it as Hold security.

On annual basis FY 2016 estimate trends at current was for $0.90 as compared to one month ago of $1.09, and for next year per share earnings estimates have $1.08.

The stock is going forward its fifty-two week low with 24.84% and lagging behind from its 52-week high price with -62.68%. Similar, the positive performance for the quarter recorded as -7.79% and for the year was -42.86%, while the YTD performance remained at 8.92%. SBGL has Average True Range for 14 days of 0.39.

 

About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *